Stock News

Groesbeck Investment Management Trimmed Caretrust Reit Com Com (CTRE) Stake by $722,800; Market Value Rose; As Monsanto Co New (Put) (MON) Stock Rose, Holder Tig Advisors Lowered Holding by $10.28 Million

Monsanto Company (NYSE:MON) Logo

Carl Tiedemann decreased its stake in Monsanto Co New (Put) (MON) by 32.99% based on its latest 2018Q1 regulatory filing with the SEC. Tig Advisors Llc sold 88,600 shares as the company’s stock rose 2.93% while stock markets declined. The hedge fund run by Carl Tiedemann held 180,000 shares of the agricultural chemicals company at the end of 2018Q1, valued at $21.00M, down from 268,600 at the end of the previous reported quarter. Tig Advisors Llc who had been investing in Monsanto Co New (Put) for a number of months, seems to be less bullish one the $56.46 billion market cap company. The stock increased 0.02% or $0.02 during the last trading session, reaching $127.95. About 7.06M shares traded or 57.73% up from the average. Monsanto Company (NYSE:MON) has risen 8.56% since June 14, 2017 and is uptrending. It has underperformed by 4.01% the S&P500. Some Historical MON News: 11/05/2018 – S.AFRICA’S COMPETITION TRIBUNAL -CONDITIONS FOR BAYER-MONSANTO DEAL REQUIRE MERGED ENTITY TO DIVEST, SELL ENTIRE GLOBAL LIBERTY LINK TRAIT TECHNOLOGY; 09/04/2018 – The Justice Department will allow Bayer’s deal to acquire Monsanto for $62.5 billion, Dow Jones reported; 29/05/2018 – BAYER SEES TO GET ANY OUTSTANDING APPROVALS FOR MONSANTO; 07/05/2018 – INDIA TOP COURT TO HEAR MONSANTO BT COTTON PATENT PLEA JULY 18; 07/03/2018 – Sharenet: India set to cut Monsanto’s GM cotton seed royalties by 20 pct; 22/05/2018 – INDIA ANTITRUST REGULATOR SAYS APPROVES ACQUISITION OF MONSANTO BY BAYER AG SUBJECT TO CERTAIN CONDITIONS; 21/03/2018 – Bayer wins EU approval for $62.5 bln Monsanto buy; 15/03/2018 – David S. Joachim: SCOOP: Bayer’s plan to win antitrust approval for its takeover of Monsanto hasn’t satisfied U.S. officials; 13/03/2018 – China’s commerce ministry conditionally approves Bayer’s acquisition of Monsanto; 25/05/2018 – BAYER BAYGn.DE SAYS EXPECTS TO CLOSE MONSANTO DEAL SOON

Groesbeck Investment Management Corp decreased its stake in Caretrust Reit Inc Com Com (CTRE) by 76.16% based on its latest 2018Q1 regulatory filing with the SEC. Groesbeck Investment Management Corp sold 55,600 shares as the company’s stock rose 9.51% while stock markets declined. The institutional investor held 17,400 shares of the consumer services company at the end of 2018Q1, valued at $233,000, down from 73,000 at the end of the previous reported quarter. Groesbeck Investment Management Corp who had been investing in Caretrust Reit Inc Com Com for a number of months, seems to be less bullish one the $1.28 billion market cap company. The stock increased 2.20% or $0.36 during the last trading session, reaching $16.74. About 177,341 shares traded. CareTrust REIT, Inc. (NASDAQ:CTRE) has declined 12.80% since June 14, 2017 and is downtrending. It has underperformed by 25.37% the S&P500. Some Historical CTRE News: 16/04/2018 – S&P REVISES CARETRUST REIT INC. TO RATING ‘BB-‘ FROM ‘B+’; 16/04/2018 – S&PGR Upgrades CareTrust REIT To ‘BB-‘; Otlk Stable; 16/03/2018 CareTrust REIT Raises Quarterly Dividend 10.8% to $0.205 per Share; 21/04/2018 – DJ CareTrust REIT Inc, Inst Holders, 1Q 2018 (CTRE); 26/04/2018 – Emerald Advisers Incorporated Exits Position in CareTrust; 16/03/2018 – CareTrust REIT Raises Quarterly Dividend to 20.5c From 18.5c; 08/05/2018 – CareTrust REIT 1Q Rev $38.1M; 01/05/2018 – CareTrust REIT Announces Addition of Two New Provider Relationships; 01/05/2018 – CareTrust REIT Added Trio Healthcare and Hillstone Healthcare as Post-Acute Care Providers; 08/05/2018 – CareTrust REIT 1Q EPS 19c

Another recent and important CareTrust REIT, Inc. (NASDAQ:CTRE) news was published by Fool.com which published an article titled: “The 3 Dividend Stocks You’ll Wish You’d Bought 10 Years From Now” on May 25, 2018.

Groesbeck Investment Management Corp, which manages about $250.00 million and $137.93 million US Long portfolio, upped its stake in Cognizant Technlgy Sltns Corcl Com (NASDAQ:CTSH) by 19,650 shares to 37,610 shares, valued at $3.03 million in 2018Q1, according to the filing. It also increased its holding in Nvidia Corp Com Com (NASDAQ:NVDA) by 2,725 shares in the quarter, for a total of 12,675 shares, and has risen its stake in Micron Technology Inc Com Com (NASDAQ:MU).

Analysts await CareTrust REIT, Inc. (NASDAQ:CTRE) to report earnings on August, 1. They expect $0.32 earnings per share, up 6.67% or $0.02 from last year’s $0.3 per share. CTRE’s profit will be $24.37M for 13.08 P/E if the $0.32 EPS becomes a reality. After $0.32 actual earnings per share reported by CareTrust REIT, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Among 11 analysts covering Caretrust REIT (NASDAQ:CTRE), 5 have Buy rating, 0 Sell and 6 Hold. Therefore 45% are positive. Caretrust REIT had 32 analyst reports since August 12, 2015 according to SRatingsIntel. KeyBanc Capital Markets maintained it with “Buy” rating and $20.0 target in Friday, October 27 report. As per Monday, August 24, the company rating was initiated by Raymond James. As per Thursday, May 31, the company rating was maintained by Wells Fargo. The stock of CareTrust REIT, Inc. (NASDAQ:CTRE) earned “Buy” rating by Canaccord Genuity on Thursday, March 30. The rating was maintained by Stephens on Monday, March 5 with “Buy”. The company was maintained on Thursday, November 9 by Stifel Nicolaus. As per Tuesday, March 6, the company rating was maintained by KeyBanc Capital Markets. The rating was maintained by Canaccord Genuity on Thursday, August 3 with “Buy”. On Monday, October 24 the stock rating was initiated by JMP Securities with “Mkt Perform”. The firm earned “Outperform” rating on Thursday, September 24 by RBC Capital Markets.

Investors sentiment decreased to 0.75 in Q1 2018. Its down 0.06, from 0.81 in 2017Q4. It fall, as 70 investors sold MON shares while 339 reduced holdings. 72 funds opened positions while 233 raised stakes. 311.73 million shares or 1.80% less from 317.44 million shares in 2017Q4 were reported. Luminus Mngmt Lc accumulated 210,997 shares. Fayerweather Charles holds 0.62% of its portfolio in Monsanto Company (NYSE:MON) for 3,350 shares. Valmark Advisers Incorporated holds 2,668 shares. 90 were accumulated by Hillsdale Inv Management Inc. Farmers Bank has 1,364 shares. Richard Bernstein Advsrs Ltd Co invested in 26,973 shares or 0.11% of the stock. 8,419 were accumulated by Segall Bryant Hamill Llc. Bokf Na stated it has 0.03% in Monsanto Company (NYSE:MON). Jet Cap Limited Partnership reported 0.67% of its portfolio in Monsanto Company (NYSE:MON). 11,320 were reported by Stanley. Amica Mutual Ins has invested 0.21% of its portfolio in Monsanto Company (NYSE:MON). Cap Investors, a California-based fund reported 4.08M shares. Putnam Invests Ltd Co owns 21,225 shares. Boothbay Fund Mngmt Limited Com holds 61,934 shares or 0.86% of its portfolio. Ontario Teachers Pension Plan Board holds 515,823 shares or 0.9% of its portfolio.

Tig Advisors Llc, which manages about $3.62 billion and $1.84B US Long portfolio, upped its stake in Peabody Energy Corp New by 219,976 shares to 393,876 shares, valued at $14.38M in 2018Q1, according to the filing. It also increased its holding in Time Warner Inc (NYSE:TWX) by 1.93M shares in the quarter, for a total of 1.94 million shares, and has risen its stake in Nxstage Medical Inc (NASDAQ:NXTM).

Analysts await Monsanto Company (NYSE:MON) to report earnings on June, 27. They expect $2.19 earnings per share, up 13.47% or $0.26 from last year’s $1.93 per share. MON’s profit will be $966.41M for 14.61 P/E if the $2.19 EPS becomes a reality. After $3.22 actual earnings per share reported by Monsanto Company for the previous quarter, Wall Street now forecasts -31.99% negative EPS growth.

Among 23 analysts covering Monsanto Company (NYSE:MON), 10 have Buy rating, 1 Sell and 12 Hold. Therefore 43% are positive. Monsanto Company had 63 analyst reports since August 25, 2015 according to SRatingsIntel. As per Wednesday, July 12, the company rating was downgraded by Jefferies. The firm has “Sell” rating by Goldman Sachs given on Monday, April 11. As per Thursday, August 27, the company rating was reinitiated by Morgan Stanley. The stock of Monsanto Company (NYSE:MON) earned “Buy” rating by Deutsche Bank on Thursday, September 15. The firm has “Hold” rating given on Friday, September 15 by Jefferies. The stock has “Hold” rating by RBC Capital Markets on Monday, November 13. The rating was maintained by Canaccord Genuity on Thursday, August 27 with “Buy”. BMO Capital Markets maintained the shares of MON in report on Wednesday, October 4 with “Buy” rating. The firm earned “Hold” rating on Wednesday, January 17 by Wells Fargo. Citigroup downgraded the stock to “Hold” rating in Monday, March 14 report.

More important recent Monsanto Company (NYSE:MON) news were published by: Seekingalpha.com which released: “Market Needs More Leaders – Cramer’s Mad Money (6/5/18)” on June 06, 2018, also Finance.Yahoo.com published article titled: “Warren Buffett’s Cash “Problem” Just Got $2.4 Billion Worse”, Streetinsider.com published: “Bayer Closes Acquisition of Monsanto (MON)” on June 07, 2018. More interesting news about Monsanto Company (NYSE:MON) was released by: Seekingalpha.com and their article: “Sell Twitter On The S&P 500 Inclusion Pop” with publication date: June 06, 2018.

Monsanto Company (NYSE:MON) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *